Nurix Therapeutics, Inc. · NASDAQ:NRIX

van Houte Hans sold 14,055 Nurix Therapeutics, Inc. shares (Form 4)

Traded May 5, 2026 · Filed May 5, 2026

On May 5, 2026, van Houte Hans (Chief Financial Officer) sold 14,055 Nurix Therapeutics, Inc. shares at an average US$16.60 for US$233K under a trading plan, leaving 37,592 shares. Filed May 5, 2026 (Form 4).

Sold
14,055 shares
Price
US$16.60 average (US$16.58 to US$17.18)
Value
US$233K
Holding after
37,592 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 5, 2026Common StockSale13,473US$16.5838,174Direct
May 5, 2026Common StockSale582US$17.1837,592Direct

Source

View original at SEC

Related